Search Bar & Filters
Found 3 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the safety and effectiveness of divarasib combined with pembrolizumab compared with pembrolizumab plus pemetrexed and carboplatin or cisplatin for adults with KRAS G12C-mutated, advanced or metastatic non-squamous non-small cell lung cancer NSCLC who have not received prior treatment. This phase 3 randomized study aims to find the best first-line therapy option for this specific lung cancer type. Participants are randomly assigned to one of two groups one group receives divarasib orally once daily and pembrolizumab through intravenous infusion every three weeks, while the other group receives pembrolizumab, pemetrexed, and carboplatin or cisplatin all by intravenous infusion every three weeks. The study treatments are given as first-line therapy, and participants are monitored for up to approximately five years. During the study, participants undergo regular assessments including scans to measure tumor response, evaluations of lung cancer symptoms like cough and breathlessness, quality of life questionnaires, and monitoring for side effects. Researchers track progression-free survival and overall survival for up to about five years. Safety and symptom severity are closely followed throughout the study, providing comprehensive data on treatment impact and participant well-being.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating a new approach to early infant motor development screening using an artificial intelligence AI algorithm combined with a mobile application called Baby Go version 3.0. This observational study focuses on infants aged 2 to 18 months, including both term and preterm infants, aiming to improve early detection and follow-up of motor disorders. The study also compares parental reports with AI-driven assessments and investigates the usability of the app for parents and clinicians. The study involves parents using the Baby Go app at home to record videos of their infants movements in various positions, such as prone, supine, sitting, and standing, every two weeks between 2 and 18 months of age. These videos are uploaded through the app for AI analysis and comparison with trained physiotherapist annotations. The study includes around 100 preterm infants, 20 term infants, 120 parents, and 2 clinicians. The app also provides educational and follow-up functions to support parents. Participants will be assessed using the Alberta Infant Motor Scale and walking age attainment measures. Parents and clinicians will complete surveys about their experience with the app at specific infant ages. The study will analyze AI model accuracy, parental perception, and the predictive validity of motor assessments. Overall, the study involves remote monitoring, video evaluations, user feedback, and data analysis over the infants first 18 months.
Actively Recruiting
Researchers are studying older adults who have been newly diagnosed with locally advanced or advanced non-small cell lung cancer and their primary family caregivers. The study aims to understand the current physical and emotional challenges these patients and caregivers face, as well as to evaluate the effects of a specialized Nurse-Led Caregiver Support Model ICSM designed to improve caregiver quality of life and resource use. The study has two phases over three years. Phase I is a cross-sectional study assessing distress, unmet needs, social support, and health practices among patients and caregivers. Phase II is a 12-month randomized trial comparing two groups one receiving the ICSM plus oncology case manager care and usual hospital care, and the other receiving oncology case manager care with usual hospital care. The ICSM intervention includes nurse-led education, counseling, symptom management, emotional coping, problem-solving, social resource use, caregiving activity planning, and access to a web-based or mobile resource platform. Participants will be assessed at the start and at multiple points up to 12 months after their first cancer treatment. Researchers will measure changes in caregiver quality of life, resource use, strain, anxiety, depression, sleep quality, as well as patient quality of life and supportive care needs. The study involves questionnaires, interviews, and resource utilization tracking to monitor the effects of the intervention and supportive care over time.